• 1
    Halberstadt AL. The phencyclidine-glutamate model of schizophrenia. Clin. Neuropharmacol. 1995; 18: 237249.
  • 2
    Krystal JH, Karper LP, Seibyl JP et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch. Gen. Psychiatry 1994; 51: 199214.
  • 3
    Javitt DC, Zylberman I, Zukin SR, Heresco-Levy U, Linden-mayer J. Amelioration of negative symptoms in schizophrenia by glycine. Am. J. Psychiatry 1994; 151: 12341236.
  • 4
    Van Berckel BNM, Hijman R, Van Der Linden JA, Westenberg HGM, Van Ree JM, Kahn RS. Efficacy and tolerance of d-cycloserine in drug-free schizophrenic patients. Biol. Psychiatry 1996; 40: 12981300.
  • 5
    Satoh K, Yanai H, Senda T et al. DAP-1, a novel protein that interacts with the guanylate kinase-like domains of hDLG and PSD-95. Genes Cells 1997; 2: 415424.
  • 6
    Takeuchi M, Hata Y, Hirao K, Toyoda A, Irie M, Takai Y. SAPAPs: A family of PSD-95/SAP90-associated proteins localized at postsynaptic density. J. Biol. Chem. 1997; 272: 11 943–11 951.
  • 7
    Kajimoto Y, Shirakawa O, Lin X.-H. et al. Synapse-associated protien 90/postsynaptic density-95-associated protein (SAPAP) is expressed differentially in phencyclidine-treated rats and is increased in the nucleus accumbens of patients with schizophrenia. Neuropsychopharmacology in press.
  • 8
    Scannevin RH, Huganir RL. Postsynaptic organization and regulation of excitatory synapses. Nat. Rev. 2000; 1: 133141.
  • 9
    Berrettini W, Ferraro T, Goldin L et al. Chromosome 18 DNA markers and manic depressive illness: Evidence for a susceptibility gene. Proc. Natl Acad. Sci. USA 1994; 91: 59185921.
  • 10
    Schwab SG, Hallmayer J, Lerer B et al. Support for a chromosome 18p locus conferring susceptibility to functional psychoses in families with schizophrenia, by association and linkage analysis. Am. J. Hum. Genet. 1998; 63: 11391152.
  • 11
    Haga H, Yamada R, Ohnishi Y, Nakamura Y, Tanaka T. Gene-based SNP discovery as part of the Japanese Millennium Genome Project: Identification of 190562 genetic variations in the human genome. J. Hum. Genet. 2002; 47: 605610.
  • 12
    Berrettini WH. Are schizophrenic and bipolar disorders related? A review of family and molecular studies. Biol. Psychiatry 2000; 48: 531538.